Related Experiment Video
Updated: Aug 23, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia
Emily S van Aalst-Cohen1, Angelique C M Jansen, Saskia de Jongh
1Department of Vascular Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Insights
Heterozygous familial hypercholesterolemia (FH) is an inherited lipid disorder causing high LDL cholesterol and early heart disease. Diagnosis relies on genetic testing, while statins and new drugs improve treatment outcomes.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Metabolic Disorders
Background:
- Familial hypercholesterolemia (FH) is a prevalent inherited disorder affecting lipoprotein metabolism.
- Characterized by elevated low-density lipoprotein cholesterol (LDL-C), tendon xanthomas, and premature cardiovascular disease.
- Monogenic cause (LDL-receptor gene mutations) but variable disease severity suggests other influencing factors.
Purpose of the Study:
- To provide an updated review of heterozygous familial hypercholesterolemia (FH).
- To cover clinical presentation, diagnostic approaches, and therapeutic strategies.
- To highlight advancements in lipid-lowering treatments.
Main Methods:
- Review of clinical, diagnostic, and therapeutic aspects of FH.
- Analysis of diagnostic criteria including clinical features, family history, and biochemical parameters.
- Discussion of current and emerging lipid-lowering therapies.
Main Results:
- Genetic mutations in the low-density-lipoprotein-receptor gene are the definitive diagnostic marker for FH.
- Clinical phenotype varies widely, influenced by additional environmental, metabolic, and genetic risk factors.
- Statins have significantly improved cardiovascular outcomes in FH patients since 1989.
Conclusions:
- Accurate diagnosis of FH is crucial for timely intervention.
- Management involves a combination of lifestyle, pharmacotherapy, and monitoring for other risk factors.
- Ongoing development of novel lipid-lowering agents promises further therapeutic advancements.
Abstract:
Heterozygous familial hypercholesterolemia (FH) is a common inherited disorder of lipoprotein metabolism. FH is characterized by elevated levels of low-density lipoprotein cholesterol, the presence of tendon xanthomas, and premature cardiovascular disease. The underlying molecular defect of FH consists of mutations in the gene coding for the low-density-lipoprotein-receptor protein, detection of which provides the only unequivocal diagnosis. Although the cause of FH is monogenic, there is wide variation in the onset and severity of atherosclerotic disease in these patients. Additional atherogenic risk factors of environmental, metabolic, and genetic origin are presumed to influence the clinical phenotype in FH. Criteria used to identify individuals with FH include a combination of clinical characteristics, personal and family history of early coronary artery disease, and biochemical parameters. Since the introduction in 1989 of statins, which have been shown to be effective and to delay or prevent the onset of cardiovascular disease, drug treatment of FH has greatly improved. New lipid-lowering agents are presently being developed for clinical use. This review provides an update on the clinical, diagnostic, and therapeutic aspects of heterozygous familial hypercholesterolemia.
Related Concept Videos
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Pharmacogenomics: Identification of New Drug Targets
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Atherosclerosis III: Management
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
